Burggraaf B, et al. - In this study, researchers assessed the progression of carotid intima media thickness (cIMT) in rheumatoid arthritis (RA) patients subjected to a cardiovascular treat-to-target intervention. They also assessed the presence of the metabolic syndrome (MetS) on cIMT outcomes. Findings demonstrated an increased cardiovascular disease (CVD) risk profile among RA patients with MetS, based on both a higher prevalence of CVD risk factors and structural vascular changes. A reduction in cIMT progression resulting from a treat-to-target approach of CVD risk factors was evident only in RA patients without MetS.